Correspondence 0001493152-23-042724 from Tharimmune, Inc. (THAR) (CIK 0001861657) (THAR)

Tharimmune, Inc. (THAR) (CIK 0001861657)
Date: Nov. 27, 2023 · CIK: 0001861657 · Accession: 0001493152-23-042724

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-275350

Date

Nov. 27, 2023

Author

Randy Milby

Form

CORRESP

Company

Tharimmune, Inc. (THAR) (CIK 0001861657)

Letter

Tharimmune, Inc.

Route 22 East, Suite 2000

Bridgewater, NJ 08807

November 27, 2023

VIA EDGAR

United States Securities and Exchange Commission

F Street, N.E.

Washington, D.C. 20549

Attention: Daniel Crawford

Re: Tharimmune, Inc.

Registration Statement on Form S-1

File No. 333-275350

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Tharimmune, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Monday, November 27, 2023, or as soon thereafter as possible.

Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

THARIMMUNE, INC.

By: /s/ Randy Milby

Name: Randy Milby

Title: Chief Executive Officer

Show Raw Text

CORRESP
1
filename1.htm

Tharimmune,
Inc.

1200
Route 22 East, Suite 2000

Bridgewater,
NJ 08807

    November
    27, 2023

VIA
EDGAR

United
States Securities and Exchange Commission

100
F Street, N.E.

Washington,
D.C. 20549

Attention:
Daniel Crawford

    Re:
    Tharimmune,
    Inc.

    Registration
    Statement on Form S-1

    File
    No. 333-275350

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Tharimmune, Inc. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective
at 5:00 p.m., Eastern Standard Time, on Monday, November 27, 2023, or as soon thereafter as possible.

Please
notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible
as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

    THARIMMUNE,
    INC.

    By:
    /s/
    Randy Milby

    Name:
    Randy
    Milby

    Title:
    Chief
    Executive Officer

SecProbe.io